2025-08-29 - Analysis Report
Okay, here's the analysis of Natera Inc. (NTRA), presented as a report in English with key figures and commentary.

## Natera Inc. (NTRA) Stock Analysis Report

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing.

### 1. Relative Performance vs. S&P 500 (VOO)

*   **Cumulative Return (NTRA):** 160.09%
*   **Cumulative Return (VOO):** 102.90%
*   **Absolute Deviation:** 57.19%
*   **Relative Deviation:** 86.7 (Indicates NTRA's outperformance is in the upper range of its historical deviation from VOO)
*   **Deviation Range:** Max: 696.2, Min: -83.2, Current: 592.2

**Analysis:** NTRA has significantly outperformed the S&P 500 (VOO) over the analyzed period. The relative deviation of 86.7 suggests that this outperformance is substantial compared to its historical range. However, the high maximum deviation (696.2) indicates the stock's potential for large swings in performance relative to the market.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD      | Alpha   | Beta   | Cap(B) |
|------------|----------|----------|---------|--------|--------|
| 2015-2017  | -6.0%    | 62.4%    | -31.0%  | 0.0    | 1.2    |
| 2016-2018  | 29.0%    | 80.1%    | 11.0%   | 0.0    | 1.9    |
| 2017-2019  | 159.0%   | 80.1%    | 130.0%  | 1.2    | 4.6    |
| 2018-2020  | 530.0%   | 80.1%    | 510.0%  | 0.3    | 13.7   |
| 2019-2021  | 355.0%   | 62.9%    | 307.0%  | 0.2    | 12.8   |
| 2020-2022  | -119.0%  | 62.9%    | -121.0% | 0.2    | 5.5    |
| 2021-2023  | -482.0%  | 69.9%    | -500.0% | 1.1    | 8.6    |
| 2022-2024  | -75.0%   | 70.6%    | -100.0% | 1.2    | 21.7   |
| 2023-2025  | 109.0%   | 76.1%    | 54.0%   | 0.8    | 23.0   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) fluctuates significantly, indicating periods of high growth and substantial decline. The most recent period (2023-2025) shows a positive CAGR of 109.0%.
*   **MDD:** Maximum Drawdown (MDD) remains consistently high, generally above 60%, reflecting the high volatility and risk associated with the stock.
*   **Alpha:** Alpha values vary widely, with some periods showing significant outperformance (e.g., 510.0% in 2018-2020) and others showing underperformance (e.g., -500.0% in 2021-2023). Recent Alpha is 54.0%, suggesting recent outperformance.
*   **Beta:** Beta values are generally low, hovering around 0 to 1.2, suggesting that NTRA's price movements are not strongly correlated with the overall market.
*   **Cap(B):** Market capitalization has grown over time, indicating increasing investor interest and company growth, although it has fluctuated with the stock's performance.

### 2. Recent Stock Price Performance

*   **Current Price:** 167.88
*   **Previous Close:** 163.04
*   **Change:** 2.97
*   **5-Day Moving Average:** 164.94
*   **20-Day Moving Average:** 155.35
*   **60-Day Moving Average:** 156.53

**Analysis:** The stock price has increased recently, closing at 167.88 with a change of 2.97. The current price is above the 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3266 (Low Risk)
*   **RSI:** 71.21 (Overbought)
*   **PPO:** 0.81
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.32)
*   **Delta_Previous_Relative_Divergence:** 1.0 (+) (Short-term increase in relative outperformance)
*   **Expected Return:** 54.9% (Long-term, relative to S&P 500)

**Analysis:**

*   The Market Risk Indicator (MRI) is low, suggesting a relatively stable market environment for this stock.
*   The RSI is above 70, indicating an overbought condition, which might suggest a potential pullback or consolidation in the short term.
*   PPO (Percentage Price Oscillator) indicates the level of momentum in the price.
*   The positive change in relative divergence suggests that the stock has recently started outperforming its benchmark.
*   The high expected return (54.9%) suggests that analysts anticipate significant outperformance relative to the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **2025-08-28:** Major business developments, regulatory changes, or market events impacting Natera.
*   **2025-08-25:** Analyst discussions on Natera's recent performance, industry trends, and global economic factors.
*   **2025-08-27:** Notable stock volatility due to recent news, earnings reports, or executive actions.
*   **2025-08-29:** Market experts highlight risks and opportunities, advising monitoring of recent news and announcements.

**Analysis:** Recent news indicates significant activity and volatility surrounding Natera Inc. Investors should closely monitor news and company announcements to understand the factors driving these movements.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-08-08 | -0.74 | 0.55 B$  |
| 2025-05-09 | -0.50 | 0.50 B$  |
| 2024-11-12 | -0.26 | 0.44 B$  |
| 2024-08-09 | -0.30 | 0.41 B$  |
| 2025-08-08 | -0.30 | 0.41 B$  |

**Analysis:**

*   The company has consistently reported negative Earnings Per Share (EPS) over the observed periods. The recent EPS is -0.74.
*   Revenue has been increasing, suggesting top-line growth. The most recent revenue is 0.55 B$.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $0.55B    | 63.41%        |
| 2025-03-31 | $0.50B    | 63.12%        |
| 2024-12-31 | $0.48B    | 62.94%        |
| 2024-09-30 | $0.44B    | 61.79%        |
| 2024-06-30 | $0.41B    | 58.83%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | $1.25B    | -8.10%    |
| 2025-03-31 | $1.24B    | -5.40%    |
| 2024-12-31 | $1.20B    | -4.50%    |
| 2024-09-30 | $0.88B    | -3.60%    |
| 2024-06-30 | $0.84B    | -4.48%    |

**Analysis:**

*   **Revenue:** Revenue has shown consistent growth over the quarters.
*   **Profit Margin:** The profit margin is relatively high and stable, indicating effective cost management relative to revenue.
*   **Equity:** Total equity has been increasing, reflecting potential capital accumulation or investment.
*   **ROE:** The Return on Equity (ROE) is negative, which aligns with the negative EPS.

### 7. Overall Summary

Natera Inc. (NTRA) presents a mixed picture for investors. The company has shown significant outperformance compared to the S&P 500 and has exhibited strong revenue growth and profit margins. However, it also carries high volatility, negative earnings, and a negative ROE. Recent news suggests the company is undergoing significant developments and potential volatility. The high expected return suggests optimism for future performance, but investors should carefully weigh the risks and rewards. The recent price increase and upward trend in moving averages may indicate short-term positive momentum, but the overbought RSI suggests caution.
